Navigation Links
RSB Spine, LLC Announces FDA Clearance of New InterPlate(TM) Indications
Date:9/22/2007

CLEVELAND, Sept. 20 /PRNewswire/ -- RSB Spine, LLC, today announced the U.S. Food and Drug Administration has cleared the cervical and lumbar InterPlate(TM) devices for use in intervertebral fusion procedures. Included are versions to be used with solid bone grafts and morselized bone, without the need for supplemental fixation.

Fusion is one of the most common spinal procedures performed by neurosurgeons and orthopedic spine surgeons. The InterPlate is designed to facilitate rapid fusion and is used in conjunction with graft material to fuse spinal vertebrae together. Previously the InterPlate had only been approved for use as a vertebral body replacement in the thoraco-lumbar spine.

John A. Redmond, Chief Executive Officer, said, "We are pleased that the InterPlate is one of the first systems cleared by FDA since interbody fusion devices were reclassified on July 12. Now that cervical indications are available the platform can realize its full potential. This greatly expands the options our growing distribution network can provide surgeons."

James M. Moran, Chief Technical Officer, added "We feel the design of the InterPlate combines all the advantages of existing plates and interbody devices, without any of the disadvantages. Once the PEEK (polyetheretherketone) version of the InterPlate is approved in the first quarter of 2008 it will provide surgeons with a unique new option, not currently available from any other company."

RSB Spine is a privately held medical device company focused on developing innovative spinal implants. In 2004, RSB Spine sold its surgical instrument line to Jarit, an Integra LifeSciences Holding Corp. company, and in 2005 sold its cervical plate system to NuVasive, Inc.


'/>"/>
SOURCE RSB Spine, LLC
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... (PRWEB) , ... May 24, ... ... announcement of Essette Dashboard, its highly anticipated, web-based software module. The cutting-edge ... The application’s “secret sauce”? Integration with Izenda’s self-service business intelligence solution and ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... anniversary and has kicked off its 5th Annual Photo Contest. The label contest ... annual event. This year's prizes include a GoPro Hero4, a 40-inch high-definition flat-screen ...
(Date:5/23/2016)... ... May 23, 2016 , ... On Sunday, May 15, ... million, 64-room assisted living center. After 18 months of construction, the new state-of-the-art ... new building provides the latest in assisted living amenities and services, offering six ...
(Date:5/23/2016)... ... 2016 , ... Edward D. Buckingham, M.D . is excited announce that ... roster is put out by the National Consumer Advisory Board to honor excellence in ... considered for this award. , The National Consumer Advisory Board (NCAB) is a private ...
(Date:5/23/2016)... ... , ... According to an article published May 11th on The ... who could benefit from bariatric surgery are actually undergoing the procedure. The article explains ... it offers to obese patients from 6,000 to 50,000 a year, it will not ...
Breaking Medicine News(10 mins):
(Date:5/22/2016)... 23, 2016 DS Biopharma ... and anti-inflammatory compound DS102 in chronic obstructive pulmonary ... steatohepatitis (NASH) patients. Recent DS preclinical ... lung tissue and has bronchodilatory, anti-inflammatory and anti-fibrotic ... The Company will publish further detail on these ...
(Date:5/20/2016)... ReportsnReports.com adds "Plaque Psoriasis ... research report with comprehensive information on the therapeutic ... comparative analysis at various stages, therapeutics assessment by ... administration (RoA) and molecule type, along with latest ... also reviews key players involved in the therapeutic ...
(Date:5/19/2016)... Oregon , May 19, 2016 ... titled, World Medical/Diagnostic Imaging Market -Opportunities and Forecasts, 2015 ... reach $45.0 billion by 2022, registering a CAGR of ... expected to continue to be the highest revenue-generating segment ... accounted for around one-third of the market share ...
Breaking Medicine Technology: